Towards clinical translation of nanomedicines: Formulation scale-up and model systems
Advanced Drug Delivery Reviews · 2026-07 · 234 · 115862
DOI: 10.1016/j.addr.2026.115862 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2026-07. Verfasst von Owen M Kelly und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA. Hauptthemen laut MEDLINE: Nanomedicine, Nanoparticles, Translational Research, Biomedical. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 233 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, NCRR NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Non-viral nanomedicines, including nanoparticles (NPs) composed of lipids and polymers, represent a transformative approach to drug and gene therapy. However, clinical translation of these technologies is limited by two key barriers: the scale-up of NP formulations and the challenge of conducting predictive preclinical studies in relevant animal models. Efficient upscaling of nanomedicines, from cost and material requirement perspectives, requires manufacturing processes that can reliably provide products across the many orders of magnitude of scale from discovery ( kg of product). Additionally, initial preclinical studies are often performed in mouse models for discovery; however, mid- to large-size animal models such as rabbits, pigs, sheep, and nonhuman primates are more relevant to human scale and physiology in the context of evaluating the safety, efficiency, and efficacy of therapeutic strategies proposed for use in humans across age groups. This review summarizes some current strategies to scale-up the production of nanomedicines for translational investigations. Animal models and new approach methodologies are also addressed for NP assessment and screening, including the physiological distinctions when comparing rodent models to larger species that can impact NP delivery. Current challenges are also highlighted in terms of scale-up and preclinical validation with the objective of highlighting scalable, effective nanomedicine platforms that can be considered for translation to human trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA.
- Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, USA.
- Division of Animal Sciences and the National Swine Testing Center, University of Missouri, Columbia, MO, USA.
- Department of Animal, Dairy and Veterinary Sciences, Utah State University, Logan, UT, USA.
- The Jackson Laboratory, Bar Harbor, ME, USA.
- National Center of Rabbit Models for Translational Research, University of Michigan Medical School, Ann Arbor, MI, USA.
Förderung
- NIH HHS
- NCRR NIH HHS
- NHLBI NIH HHS
- National Science Foundation
- National Institutes of Health Office of the Director
- Pharmaceutical Research and Manufacturers of America Foundation
- National Institutes of Health
- Wellcome Trust
Zitieren
APA
Kelly, O. M., Hanna, A. R., Byrne, A. K., Green, J. A., Perisse, I. V., Wells, K. D., Murray, S. A., Xu, J., Chen, Y. E., Polejaeva, I. A., Tarantal, A. F., Issadore, D., & Piotrowski-Daspit, A. S. (2026). Towards clinical translation of nanomedicines: Formulation scale-up and model systems. Advanced Drug Delivery Reviews, 234, 115862. https://doi.org/10.1016/j.addr.2026.115862
Vancouver
Kelly OM, Hanna AR, Byrne AK, Green JA, Perisse IV, Wells KD, et al. Towards clinical translation of nanomedicines: Formulation scale-up and model systems. Advanced Drug Delivery Reviews. 2026;234:115862. doi:10.1016/j.addr.2026.115862
BibTeX
@article{Kelly2026,
author = {Kelly, Owen M and Hanna, Andrew R and Byrne, Addison K and Green, Jonathan A and Perisse, Iuri Viotti and Wells, Kevin D and Murray, Stephen A and Xu, Jie and Chen, Y Eugene and Polejaeva, Irina A and Tarantal, Alice F and Issadore, David and Piotrowski-Daspit, Alexandra S},
title = {Towards clinical translation of nanomedicines: Formulation scale-up and model systems},
journal = {Advanced Drug Delivery Reviews},
year = {2026},
volume = {234},
pages = {115862},
doi = {10.1016/j.addr.2026.115862}
}
EUVIMED